Načítá se...
Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar
BACKGROUND: Etanercept is prescribed for the rapid and effective treatment of chronic immune-mediated inflammatory disorders. Due to the expiration of etanercept patents and worldwide demand for comparable and more affordable substitutes, several biosimilars of etanercept have been approved in diffe...
Uloženo v:
| Vydáno v: | Iran J Biotechnol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
National Institute of Genetic Engineering and Biotechnology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357702/ https://ncbi.nlm.nih.gov/pubmed/32671128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.30498/IJB.2019.99581 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|